PTPN1 and neoplasm: Nevertheless, since PTP1B deficiency or inhibition has also been reported to hinder the growth of various tumors through enhancement of T cell-mediated anti-tumor responses (67), strict selectivity over PTP1B may not be required, and limited selectivity could even enhance therapeutic efficacy (68).